Foyou Pharma: 6 products are expected to be selected for the 11th batch of national centralized drug procurement

Zhitong
2025.10.29 10:37

Foyou Pharma announced that six of its products are expected to be selected in the 11th national centralized drug procurement, including Fumaric Acid Lurasidone Tablets, Pravastatin Sodium Tablets, Cilostazol Tablets, Alendronate Sodium Tablets, Agomelatine Tablets, and Dopamine Hydrazine Tablets. If these products are selected and sales contracts are signed, it will help increase market share and have a positive impact on the company's future operating performance. At the same time, the products that the company did not win bids for, such as Dapagliflozin Tablets, did not generate sales in 2024, and the sales amount from January to September 2025 was 2.9413 million yuan, accounting for 0.1167% of the company's operating income during the same period, which will not have a significant impact on the company's production and operations

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.